Aortic stenosis market developments and opportunities (2026–2030)

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Aortic Stenosis Market Progress Between 2026 And 2030?

The aortic stenosis market size has experienced swift growth in recent years. It is projected to expand from $8.91 billion in 2025 to $10.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.9%. The historical market expansion can be linked to factors like a progressively aging global population, the increasing incidence of degenerative heart valve diseases, the proliferation of cardiac catheterization laboratories, improvements in surgical valve replacement methods, and a heightened clinical understanding of valvular disorders.

The aortic stenosis market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $16.17 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is fueled by several factors, including heightened investments in advanced valve technologies, a surge in the uptake of TAVR procedures, the broadening of outpatient cardiac care services, an increased emphasis on early intervention approaches, and the greater integration of digital tools for cardiac monitoring. Key developments expected in this period encompass the growing adoption of transcatheter valve replacement procedures, an escalating need for cardiac interventions that are minimally invasive, wider utilization of sophisticated diagnostic imaging, the spread of customized valve therapy options, and a stronger focus on identifying diseases at an earlier stage.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

What Key Drivers Are Fueling The Growth Of The Aortic Stenosis Market?

The rising occurrence of heart conditions is projected to boost the growth of the aortic stenosis market. Heart diseases encompass a spectrum of ailments that impact the heart’s architecture and operation, potentially impairing its ability to effectively pump blood and leading to various complications. Common examples include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy. Aortic stenosis, specifically, involves a constriction of the aortic valve, obstructing blood flow from the left ventricle into the aorta. This heightened resistance forces the heart to exert more effort, which over time can result in heart failure and other cardiovascular problems. Effective management of aortic stenosis, such as valve replacement or TAVI, contributes to improved cardiac function and diminishes the risk of severe heart disease outcomes. For instance, in January 2025, the British Heart Foundation, a UK-based cardiovascular research charity, stated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, including about 4 million males and 3.6 million females. These conditions are attributed to roughly 27% of all deaths in the UK, causing over 170,000 fatalities annually, which equates to 480 deaths per day. Consequently, the growing prevalence of heart diseases is serving as a significant driver for the aortic stenosis market.

How Are Segments Identified Within The Aortic Stenosis Market Segment Framework?

The aortic stenosis market covered in this report is segmented –

1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

3) By End User: Hospitals and Cardiac Centers, Ambulatory Surgical Centers, Cardiac Surgeons and Interventional Cardiologists

Subsegments:

1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

What Trends Are Influencing The Aortic Stenosis Market?

Major companies operating in the aortic stenosis market are prioritizing the development of innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems. These advancements aim to enhance patient outcomes, diminish procedural risks, and improve the overall effectiveness of treatment for aortic conditions. A transcatheter aortic valve implantation (TAVI) system is a minimally invasive medical device designed to replace a diseased aortic valve without requiring open-heart surgery. For example, in January 2023, Abbott Laboratories, a US-based medical device company, secured approval from the U.S. Food and Drug Administration (FDA) for Navitor, its latest-generation transcatheter aortic valve implantation (TAVI) system. Navitor incorporates the NaviSeal fabric cuff, which is intended to reduce or eliminate paravalvular leaks. The system’s architectural design, featuring leaflets positioned within the native valve, is intended to enhance accessibility to coronary arteries for future treatments of coronary artery disease.

Who Are The Companies Competing Within The Aortic Stenosis Market?

Major companies operating in the aortic stenosis market are Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, CryoLife Inc, Anteris Technologies Ltd, Venus Medtech, Peijia Medical, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, Symetis SA, Artivion Inc, HighLife SAS, Transcatheter Technologies GmbH, NaviGate Cardiac Structures Inc, Xeltis BV, Sorin Group, Meril Life Sciences Pvt Ltd, On-X Life Technologies Inc, Braile Biomédica, Colibri Heart Valve

Get The Full Aortic Stenosis Market Report:

https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

Which Region Is The Largest In The Aortic Stenosis Market?

North America was the largest region in the aortic stenosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Aortic Stenosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

Browse Through More Reports Similar to the Global Aortic Stenosis Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Endograft Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795